Pharmafile Logo
Pharmafocus logo
Advanced Search

partnership

Showing 15 posts of 25 posts found.

Allumiqs and Prolytix enter partnership for acceleration of drug discovery and development

March 15, 2024
Research and Development Allumiqs, Pharmacy, drug discovery, partnership

Allumiqs and Prolytix have announced that they have entered into a long-term, strategic partnership with the aim of providing collaboratinve …

News

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023
Research and Development NAYA Biosciences, NK cell therapies, ONK Therapeutics, Oncology, partnership

ONK Therapeutics and NAYA Biosciences have announced that they have entered into a research partnership to assess combination therapies consisting …

News
shutter

UCB syncs up with Roche and Genentech in Alzheimer’s drug deal worth a potential $2bn+

July 30, 2020
Research and Development, Sales and Marketing Genentech, Roche, UCB, partnership

UCB Pharma is set to partner up with Roche and Genentech in a development and commercialisation deal focused on its …

News
shutterstock_273326141

AstraZeneca partners with Daichii Sankyo in potential $6bn cancer drug deal

July 27, 2020
Research and Development, Sales and Marketing AstraZeneca, Daiichi Sankyo, partnership, pharma

AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062, a trophoblast cell-surface …

News
takeda_world

Takeda partners up with Carmine Therapeutics to develop and market rare disease candidates

July 1, 2020
Research and Development Takeda Carmine, partnership, pharma

Takeda has linked up with Carmine Therapeutics in a new partnership to discover, develop and bring to market new non-viral …

News
shutterstock_273326141

AbbVie and Genmab sign drug development and commercialisation deal worth up to $4bn

June 11, 2020
Research and Development AbbVie, Genmab, partnership, pharma

AbbVie has joined forces with Genmab to develop and commercialise three of the latter’s early-stage Genmab drug products – epcoritamab …

News
shutterstock_138095450

Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement

April 9, 2020
Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory

Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …

News
shutterstock_273326141

Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics

April 9, 2020
Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma

Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …

News
lilly_building_with_american_flag_web

Lilly partners with Sitryx in $880m immunometabolism drug development deal

April 1, 2020
Research and Development Eli Lilly, Sitryx, partnership, pharma

Eli Lilly and UK firm Sitryx have partnered up in a new drug development and commercialisation deal that could potentially …

News

Boehringer teams up with OSE in €1.1 billion cancer drug partnership

April 5, 2018
Sales and Marketing Boehringer, Cancer, OSE Immunotherapeutics, partnership, pharma

Boehringer Ingelheim and biotech firm OSE Immunotherapeutics have announced that they have entered an exclusive collaboration and license agreement to …

News
shutterstock_273326141

Abcam acquires rights to over 700 Roche products in new licensing deal

January 22, 2018
Sales and Marketing Abcam, Roche, partnership, pharma

Roche has entered a licensing agreement Abcam which gives the British biotech exclusive access to the marketing rights for 760 …

News
takeda_world

Takeda forms “first of its kind” developmental partnership with CRO

September 13, 2016
Manufacturing and Production, Research and Development PRA Health Services, Takeda, partnership

Takeda and PRA Health Services have announced a new partnership that will see the Japanese pharma giant transfer 300 staffers …

News

FDA approves Lilly/Boehringer Ingelheim type-2 diabetes drug

June 1, 2016
Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, diabetes, jentadueto, jentadueto xr, lilly, partnership, type 2, type-2

The US Food and Drug Administration (FDA) has approved Jentadueto XR (linagliptin and metformin hydrochloride extended release) tablets for the …

News
pfizerbrussels

Pfizer teams up with Wave Life Sciences for metabolic disease research

May 6, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, metabolic disease, nucelic acid therapies, partnership, wave life sciences

Pfizer (NYSE: PFE) has entered into a research, license and option agreement with Wave Life Sciences (NASDAQ: WVE) for the …

News

Sun Pharma to partner with ICGEB to develop novel Dengue treatment

May 4, 2016
Research and Development Dengue fever, Sun Pharma, collaboration, dengue, development, drug, icgeb, international centre for genetic engineering and biotechnology, partnership, sun pharmaceutical

Sun Pharmaceuticals (BSE: 85715) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) are set to team up to …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024